Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Intangibles (2019 - 2026)

Biodesix filings provide 8 years of Intangibles readings, the most recent being $18.9 million for Q1 2026.

  • On a quarterly basis, Intangibles changed 0.45% to $18.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $18.9 million, a 0.45% change, with the full-year FY2025 number at $3.9 million, down 33.9% from a year prior.
  • Intangibles hit $18.9 million in Q1 2026 for Biodesix, up from $3.9 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $19.0 million in Q3 2024 to a low of $3.9 million in Q4 2025.
  • Median Intangibles over the past 5 years was $18.8 million (2022), compared with a mean of $13.7 million.
  • Biggest five-year swings in Intangibles: crashed 60.94% in 2024 and later soared 175.39% in 2025.
  • Biodesix's Intangibles stood at $18.9 million in 2022, then tumbled by 58.13% to $7.9 million in 2023, then decreased by 25.75% to $5.9 million in 2024, then plummeted by 33.9% to $3.9 million in 2025, then surged by 385.58% to $18.9 million in 2026.
  • The last three reported values for Intangibles were $18.9 million (Q1 2026), $3.9 million (Q4 2025), and $19.0 million (Q3 2025) per Business Quant data.